“Although (Canopy management is) still working through the challenges surrounding the onset and duration of a cannabis-infused beverage, they feel that the benefits of zero/low calories and limited hangover will drive consumers towards this product and away from beverage alcohol (management specifically highlighted beer/spirits as the two categories most at risk),” said analysts led by Andrea Teixeira.
MJ also got a boost from one of its other holdings, Cronos Group Inc–another Canadian medical marijuana company. Since mid-August, shares of Cronos Group have surged by 125%.
‘Tweed and tonic’ marijuana drinks could be coming to Canada in 2019, says Canopy Growth CEO from CNBC.
For more information on the markets, visit our current affairs category.